COVID: new antibody treatment could offer up to 18 months’ protection against severe disease
COVID: new antibody treatment could offer up to 18 months’ protection against severe disease: Antibodies (light blue) binding to the spike proteins (dark purple) on the outside of the coronavirus. Design_Cells/Shutterstock A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial – …
